Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Andersen

Showing results (501-510 of 530) with videos related to

Pageof 53
Sort By:
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adultsGillian F Black, Rosemary E Weir, Steven D Chaguluka, et al.
Vaccine|February 21, 2017
Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trialsMaria Norrby, Timo Vesikari, Lars Lindqvist, et al.
Scientific Reports|April 8, 2017
Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6Morten Ruhwald, Lena de Thurah, Davis Kuchaka, et al.
The American Journal of Clinical Nutrition|January 29, 2026
Health-related quality of life, compliance and sustained adherence on a Low-Carbohydrate High-Fat diet compared with a High-Carbohydrate Low-Fat diet in people with type 2 diabetesEllen Elise Petersen, Johanne Kragh Hansen, Nikolaj Torp, et al.
Journal of Hepatology|April 23, 2023
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver diseaseMaria Kjaergaard, Katrine Prier Lindvig, Katrine Holtz Thorhauge, et al.
Cell Stem Cell|August 14, 2018
Tbx6 Induces Nascent Mesoderm from Pluripotent Stem Cells and Temporally Controls Cardiac versus Somite Lineage DiversificationTaketaro Sadahiro, Mari Isomi, Naoto Muraoka, et al.
Plos One|December 10, 2014
Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trialKlaus Reither, Lynn Katsoulis, Trevor Beattie, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2025
MetALD: Diagnosis and Prognosis With Non-Invasive TestsNikolaj Torp, Mads Israelsen, Stine Johansen, et al.
Journal of Hepatology|July 6, 2025
Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the communityCamilla Dalby Hansen, Johanne Kragh Hansen, Mads Israelsen, et al.
Gastroenterology|December 22, 2025
Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver DiseaseNikolaj Torp, Stine Johansen, Ellen Lyngbeck Jensen, et al.
Pageof 53

Showing results (501-510 of 530) with videos related to

Sort By:
Pageof 53
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adultsGillian F Black, Rosemary E Weir, Steven D Chaguluka, et al.
Vaccine|February 21, 2017
Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trialsMaria Norrby, Timo Vesikari, Lars Lindqvist, et al.
Scientific Reports|April 8, 2017
Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6Morten Ruhwald, Lena de Thurah, Davis Kuchaka, et al.
The American Journal of Clinical Nutrition|January 29, 2026
Health-related quality of life, compliance and sustained adherence on a Low-Carbohydrate High-Fat diet compared with a High-Carbohydrate Low-Fat diet in people with type 2 diabetesEllen Elise Petersen, Johanne Kragh Hansen, Nikolaj Torp, et al.
Journal of Hepatology|April 23, 2023
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver diseaseMaria Kjaergaard, Katrine Prier Lindvig, Katrine Holtz Thorhauge, et al.
Cell Stem Cell|August 14, 2018
Tbx6 Induces Nascent Mesoderm from Pluripotent Stem Cells and Temporally Controls Cardiac versus Somite Lineage DiversificationTaketaro Sadahiro, Mari Isomi, Naoto Muraoka, et al.
Plos One|December 10, 2014
Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trialKlaus Reither, Lynn Katsoulis, Trevor Beattie, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2025
MetALD: Diagnosis and Prognosis With Non-Invasive TestsNikolaj Torp, Mads Israelsen, Stine Johansen, et al.
Journal of Hepatology|July 6, 2025
Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the communityCamilla Dalby Hansen, Johanne Kragh Hansen, Mads Israelsen, et al.
Gastroenterology|December 22, 2025
Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver DiseaseNikolaj Torp, Stine Johansen, Ellen Lyngbeck Jensen, et al.
Pageof 53